BETA: Please send your feedback!
Resolute Energy
REN:NYS
Oil & Gas Production
$721.10mm
SMALL cap
$30.91
(0.00%)
0.05%
since start of 2019
-18.34
- —
- —
- —
- —
- —
- —
- —
- —
- —
- —
- —
- 2
-
CF
-
PP
-
WC
-
DP
-
CH
-
ES
-
WS
-
CG
-
EP
-
CM
-
FL
-
GD
- —
- 1
- 2
- 3
- 4
- 5
About
Biotechnology
Founded 2009
Edge Therapeutics, Inc. operates as biotechnology company which develops therapies. engages in the discovery, development, and commercialize novel, hospital-based therapies capable of transforming treatment paradigms in the management of acute, life-threatening neurological conditions for which limited or no current therapies exist. It develops the Precisa Platform of EG-1962 and the EG-1964 treatments. The company was founded on January 22, 2009 by Brian A. Leuthner, Robert Loch Macdonald and Carl J. Soranno and is headquartered in Berkeley Heights, NJ.
website
Headquarters
Executives
| Name | Title | Gender |
| Michael N. Stefanoudakis | Secretary, EVP & General Counsel | Male |
| Nicholas Joseph Sutton | Executive Chairman | Male |
| James M. Piccone | President & Director | Male |
| Bobby D. Brady, Jr. | Senior Vice President-Operations | Male |
| Theodore Gazulis, MBA | Chief Financial Officer & Executive Vice President | Male |
| Richard F. Betz, MBA | Chief Executive Officer & Director | Male |
| Harlan Bruce Juengling | Vice President-Investor Relations | Male |
Mindful Investing Summary
- —
- 1
- 2
- 3
- 4
- 5
-
Carbon Footprint — N/A
-
Pollution Prevention — N/A
-
Water Conservation — N/A
-
Data & Privacy Protection — N/A
-
Consumer Health, Wellness & Safety — N/A
-
Employee Ownership, Satisfaction, Benefits & Pay — N/A
-
Workplace Health and Safety — N/A
-
Integrity of Corporate Governance — N/A
-
Ethical Practices — N/A
-
Usage of Conflict Materials — N/A
-
Forced Labor — N/A
-
Diversity of Corporate Leadership 2
Edge Therapeutics - Competitors and Related Companies
How Edge Therapeutics stacks up to its peers in the Biotechnology industry or with competing business segments.
Edge Therapeutics
EDGE:NAS
Biotechnology
$15.76mm
SMALL cap
$0.50
(0.00%)
0.39%
since start of 2019
-0.38
Loading…